57. Jahrestagung der Deutschen Gesellschaft für Neuropathologie und Neuroanatomie (DGNN)
Deutsche Gesellschaft für Neuropathologie und Neuroanatomie
12. - 15.09.2012, Erlangen
Poster Presentations
Tumors
Meeting Abstract
(12dgnnPP3.1)
[Volltext]
Tumor epigenetics: 5-Hydroxymethylcytosine in the human glioblastoma
Kraus T, Widmann D, Greiner A, Kolck G, Eigenbrod S, Globisch D, Wagner M, Carell T, Kretzschmar H[Volltext]
Meeting Abstract
(12dgnnPP3.2)
[Volltext]
Frequent down-regulation of bone morphogenetic protein (BMP) genes 2, 4 and 6 in murine and human medulloblastomas
Zipper P, Grünheck F, Reifenberger G[Volltext]
Meeting Abstract
(12dgnnPP3.3)
[Volltext]
Constitutive activation of Wnt signaling in neural progenitors results in disrupted proliferation and migration of neurons within in the cerebral and cerebellar cortex
Pöschl J, Grammel D, Dorostkar M, Kretzschmar H, Schüller U[Volltext]
Meeting Abstract
(12dgnnPP3.4)
[Volltext]
17-beta Estradiol increases Connexin43 expression on F-98 rat glioma cell line
Moinfar Z, Seval Ismail F, Dambach H, Hinkerohe D, Gold R, Faustmann PM[Volltext]
Meeting Abstract
(12dgnnPP3.5)
[Volltext]
Potential Role of Epithelial to Mesenchymal Transition in Meningioma
Wallesch M, Kirches E, Mawrin C[Volltext]
Meeting Abstract
(12dgnnPP3.6)
[Volltext]
ZEB1 mediates invasion and chemoresistance of glioblastoma
Siebzehnrubl F, Silver D, Tugertimur B, Deleyrolle L, Suslov O, Siebzehnrubl D, Sarkisian M, Devers K, Yachnis A, Kuepper M, Nabilsi N, Kladde M, Brabletz S, Brabletz T, Reynolds B, Steindler D[Volltext]
Meeting Abstract
(12dgnnPP3.7)
[Volltext]
miR-328 promotes glioma cell invasion via SFRP1-dependent WNT-signaling activation
Delic S, Lottmann N, Liesenberg F, Wolter M, Götze S, Zapatka M, Reifenberger G, Riemenschneider MJ[Volltext]
Meeting Abstract
(12dgnnPP3.8)
[Volltext]
Detection of meningeosis carcinomatosa micro-cell-clusters after surgery of an acute subdural haematoma – a case report
Brand C, Gundelach T, Scheuerle A, Wirtz CR, Kapapa T[Volltext]
Meeting Abstract
(12dgnnPP3.9)
[Volltext]
DNA damage and repair in glioblastoma cell lines after antitumor drugs
Annovazzi L, Caldera V, Mellai M, Piazzi A, Monzeglio O, Schiffer D[Volltext]
Meeting Abstract
(12dgnnPP3.10)
[Volltext]
Targeting mTORC1 is an effective strategy to inhibit meningioma cell tumorigenicity
Pachow D, Kirches E, Mawrin C[Volltext]
Meeting Abstract
(12dgnnPP3.11)
[Volltext]
Expression of SWI/SNF-subunit BAF170 (BRG1-associated factor 170) in peripheral and vestibular schwannomas
Stahn V, Wesemann M, Fischer S, Senner V, Peetz-Dienhard S, Masla M, Harder A[Volltext]
Meeting Abstract
(12dgnnPP3.12)
[Volltext]
Phenotypes of NF1 associated Peripheral Nerve Sheath Tumors are associated with modified Retinoic acid signaling mediated by differential CRABPII expression
Fischer S, Dombrowski A, Wilke G, Mautner VF, Friedrich RE, Heppner F, Harder A[Volltext]
Meeting Abstract
(12dgnnPP3.13)
[Volltext]
Association of neuroepithelial tumours and microscopic focal cortical dysplasias in patients with drug-resistant temporal lobe epilepsy.
Estupiñán Díaz BO, Morales Chacón LM, García Maeso I, Báez Martín MM, Lorigados Pedre L, Trápaga Quincoses O, Hidalgo Portal L, Gómez Lotti A[Volltext]
Meeting Abstract
(12dgnnPP3.14)
[Volltext]
Far Upstream Element [FUSE] Binding Protein 1 (FUBP1) expression is associated with increased proliferative activity, p53 accumulation and the presence of mutations in human gliomas
Baumgarten P, Harter PN, Tönjes M, Capper D, Blank AE, Schwamb B, Rabenhorst U, Kögel D, Rieker RJ, Plate KH, Ohgaki H, Radlwimmer B, Zörnig M, Mittelbronn M[Volltext]
Meeting Abstract
(12dgnnPP3.15)
[Volltext]
Cytomegalovirus infection as potential factor in CNS tumor development and progression
Baumgarten P, Michaelis M, Rothweiler F, Berger A, Allwin R, Starzetz T, Harter PN, Doerr HW, Cinatl jr. J, Mittelbronn M[Volltext]
Meeting Abstract
(12dgnnPP3.16)
[Volltext]
Haemangioblastoma: series of 24 cases with clinicopathological features
Epari S, Bhatkar R, Moyaidi A, Shetty P, Gupta T, Kane S, Jalali R[Volltext]
Meeting Abstract
(12dgnnPP3.17)
[Volltext]
DNT-like malformation and further neuropathological findings in a patient with Robinow syndrome
Romeike BFM, Diab M, Petersen I[Volltext]
Meeting Abstract
(12dgnnPP3.18)
[Volltext]
Functional activation of the Wnt signalling pathway in medulloblastoma cell lines.
Bradtmöller M, Guse K, Stenzel W, Ulrich T, Heppner F, Koch A[Volltext]
Meeting Abstract
(12dgnnPP3.19)
[Volltext]
Association of TET1 nuclear exclusion with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas
Müller T, Gessi M, Waha A, Isselstein LJ, Luxen D, Freihoff D, Freihoff J, Becker A, Simon M, Hammes J, Denkhaus D, zur Mühlen A, Pietsch T, Waha A[Volltext]
Meeting Abstract
(12dgnnPP3.20)
[Volltext]
Molecular analysis of MTSS1 in gliomas
Luxen D, Gessi M, Isselstein LJ, Müller T, Freihoff D, Freihoff J, Simon M, Pietsch T, Waha A, Waha A[Volltext]
Meeting Abstract
(12dgnnPP3.21)
[Volltext]
Hybrid neurofibroma / schwannoma – a molecular study
Wesemann M, Nagel I, Fischer S, Stahn V, Gesk S, Oyen F, Schneppenheim R, Siebert R, Paulus W, Harder A[Volltext]
Meeting Abstract
(12dgnnPP3.22)
[Volltext]
Spinal pilomyxoid astrocytoma developing a LOH 1p19q and cerebral metastasis
Eigenbrod S, Thon N, Jansen N, Janssen H, Mielke J, Ruiter M, la Fougère C, Peraud A, Egensperger R, Kretzschmar H[Volltext]
Meeting Abstract
(12dgnnPP3.23)
[Volltext]
Dissecting the chemokine-driven spread of B cell lymphoma cells into the central nervous system
Wagner L, Gül E, Kälin RE, Prokop S, Wilke G, Heppner FL[Volltext]
Meeting Abstract
(12dgnnPP3.24)
[Volltext]
MAPK pathway activation by GNAQ and GNA11 mutations in melanocytic tumors of the central nervous system.
Gessi M, Hammes J, Lauriola L, Dörner E, Kirfel J, Kristiansen G, zur Muehlen A, Denkhaus D, Waha A, Pietsch T[Volltext]
Meeting Abstract
(12dgnnPP3.25)
[Volltext]
KIAA1549-BRAF fusion status in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT)
Gessi M, Lambert S, Lauriola L, Waha A, Collins VP, Pietsch T[Volltext]
Meeting Abstract
(12dgnnPP3.26)
[Volltext]
A pyrosequencing based identification of histone H3.3 K27M mutations: a diagnostic tool inbrain tumors ofchildhood?
Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T[Volltext]
Meeting Abstract
(12dgnnPP3.27)
[Volltext]
Molecular analysis of Gremlin in gliomas
Isselstein LJ, Gessi M, Müller T, Luxen D, Freihoff D, Freihoff J, Scheffler B, Simon M, Pietsch T, Waha A, Waha A[Volltext]
Meeting Abstract
(12dgnnPP3.28)
[Volltext]
Rhabdomyoma of the Internal Auditory Canal – Case Report
Rizk A, Ebner F, Schuhmann M, Tatagiba M[Volltext]
Meeting Abstract
(12dgnnPP3.29)
[Volltext]
CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas
Sahm F, Koelsche C, Meyer J, Pusch S, Lindenberg K, Mueller W, Herold-Mende C, von Deimling A, Hartmann C[Volltext]
Meeting Abstract
(12dgnnPP3.30)
[Volltext]
BRAF V600E immunohistochemistry in the diagnosis of Pleomorphic xanthoastrocyomas and Gangliogliomas
Kölsche C, Schittenhelm J, Wöhrer A, Jeibmann A, Kohlhof P, Preusser M, von Deimling A, Capper D[Volltext]
Meeting Abstract
(12dgnnPP3.31)
[Volltext]
Expression patterns of EGFR-, PDGFR- and VEGFR –IHC in recurrent WHO grade III meningiomas
Geiger K, Juratli T, Mierke C, Kirsch M, Meinhardt M, Schackert G[Volltext]
Meeting Abstract
(12dgnnPP3.32)
[Volltext]
Intraoperative Alanin and histopathology are unable to demonstrate a recurrent glioblastoma, positively identified by FET PET-CT
Woischneck D, Permanetter W, Feiden W, Blumstein N[Volltext]
Meeting Abstract
(12dgnnPP3.33)
[Volltext]
Immunohistochemical analysis of cancer stem cell markers CD44 and CD133 in craniopharyngiomas
Hölsken A, Stache C, Fahlbusch R, Buchfelder M, Buslei R[Volltext]
